Free Trial
NYSE:GBS

GBS (GBS) Stock Price, News & Analysis

GBS logo
$1.77 -0.06 (-3.28%)
As of 07/11/2025

About GBS Stock (NYSE:GBS)

Key Stats

Today's Range
$1.75
$1.85
50-Day Range
$1.15
$1.98
52-Week Range
$0.36
$2.89
Volume
91,599 shs
Average Volume
955,325 shs
Market Capitalization
$26.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GBS and its competitors with MarketBeat's FREE daily newsletter.

GBS Stock News Headlines

Analyzing GBS (NYSE:GBS) & Acutus Medical (NASDAQ:AFIB)
GB's Glasspool & Cash make history with doubles title
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
See More Headlines

GBS Stock Analysis - Frequently Asked Questions

GBS's stock was trading at $1.40 at the beginning of the year. Since then, GBS stock has increased by 26.4% and is now trading at $1.77.

GBS Inc. (NYSE:GBS) announced its quarterly earnings results on Wednesday, August, 31st. The company reported ($0.14) EPS for the quarter, beating analysts' consensus estimates of ($0.18) by $0.04.

Shares of GBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GBS investors own include Athenex (ATNX), Biora Therapeutics (BIOR), Citius Pharmaceuticals (CTXR), KLX Energy Services (KLXE), BSQUARE (BSQR), Communications Systems (JCS) and Meta Platforms (META).

Company Calendar

Last Earnings
8/31/2022
Today
7/15/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NYSE:GBS
CIK
1725430
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.56)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.31 million
Net Margins
N/A
Pretax Margin
-1,907.09%
Return on Equity
-85.64%
Return on Assets
-54.42%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.33
Quick Ratio
2.33

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.44 per share
Price / Book
4.02

Miscellaneous

Outstanding Shares
14,890,000
Free Float
14,850,000
Market Cap
$26.36 million
Optionable
Not Optionable
Beta
1.32
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:GBS) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners